New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
September 27, 2012
07:26 EDTTBIO, WYY, ACLS, SPSC, CYBE, VTSS, EGHT, CAMP, UPI, VRNGCraig-Hallum to host a conference
3rd Annual Alpha Select Conference is being held in New York on September 27.
News For CAMP;CYBE;VRNG;EGHT;SPSC;UPI;VTSS;ACLS;WYY;TBIO From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
December 22, 2014
09:35 EDTVRNGVringo says High Court of Justice orders ZTE to pay company GBP600,000
Subscribe for More Information
08:08 EDTUPIUroplasty to host joint conference call
Conference call to discuss agreement to merge with Vision-Sciences, Inc. will be held on December 22 at 11 am. Webcast Link
07:09 EDTUPIUroplasty and Vision Sciences to merge to become Cogentix Medical
Uroplasty (UPI) and Vision-Sciences (VSCI) entered into a definitive merger agreement under which the two companies will combine in an all-stock transaction to create a new company expected to generate revenue of approximately $50M for the fiscal year beginning April 1, 2015. Under the terms of the agreement, which was unanimously approved by the boards of both companies, each outstanding share of Uroplasty's common stock will be exchanged for 3.6331 shares of Vision-Sciences' common stock. Upon completion of the merger, Uroplasty shareholders will own 62.5% of the shares of the combined company on a fully-diluted basis, and Vision-Sciences shareholders will own 37.5%. Following the closing of the transaction, which is expected to occur during the first half of 2015, the combined company will conduct business as Cogentix Medical (CGNT). The combined company will have its U.S. headquarters in Minnetonka, MN, where Uroplasty's current headquarters is located. Cogentix Medical will be led by Rob Kill, who will become President and Chief Executive Officer; Brett Reynolds, who will become Chief Financial Officer; and Darin Hammers, who will become Senior Vice President of Global Sales and Marketing. Cogentix Medical's board of directors will be comprised of the five representatives from Uroplasty's existing board and three representatives from Vision-Sciences' existing board.
07:08 EDTUPIUroplasty, Vision Sciences to merge in all stock transaction
Subscribe for More Information
07:06 EDTUPIUroplasty, Vision Sciences to merge in all stock transaction
Subscribe for More Information
December 19, 2014
09:39 EDTVRNGVringo COO to transition to consulting role
Subscribe for More Information
09:28 EDTVRNGVringo updates on litigation with ZTE, Google
Subscribe for More Information
December 18, 2014
09:09 EDTEGHT8x8, Inc. issued new conferencing and meeting patent by USPTO
Subscribe for More Information
December 17, 2014
11:10 EDTVRNGVringo provides update on patent infringement action against ZTE in Malaysia
Subscribe for More Information
December 16, 2014
10:44 EDTVRNGZTE says Vringo liable for Malaysia legal fees after withdrawal of action
Subscribe for More Information
December 15, 2014
12:36 EDTVRNGVringo will seek Supreme Court review of court's reversal of Google judgement
Subscribe for More Information
December 10, 2014
07:49 EDTACLSGuerrant Associates to hold a summit
Subscribe for More Information
07:46 EDTWYYWidePoint receives $4.5M option year excercise from Federal Agency customer
Subscribe for More Information
December 9, 2014
08:03 EDTACLSAxcelis wins multiple, follow-on order for Purion M and Purion XE
Subscribe for More Information
06:51 EDTVTSSVitesse management to meet with Craig-Hallum
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use